T-5224, a selective inhibitor of c-Fos/activator protein-1, attenuates lipopolysaccharide-induced liver injury in mice.

MLA

Izuta, Shinichiro, et al. “T-5224, a Selective Inhibitor of c-Fos/Activator Protein-1, Attenuates Lipopolysaccharide-Induced Liver Injury in Mice.” Biotechnology Letters, vol. 34, no. 12, Dec. 2012, pp. 2175–82. EBSCOhost, https://doi.org/10.1007/s10529-012-1022-4.

APA

Izuta, S., Ueki, M., Ueno, M., Nishina, K., Shiozawa, S., & Maekawa, N. (2012). T-5224, a selective inhibitor of c-Fos/activator protein-1, attenuates lipopolysaccharide-induced liver injury in mice. Biotechnology Letters, 34(12), 2175–2182. https://doi.org/10.1007/s10529-012-1022-4

Chicago

Izuta, Shinichiro, Masaaki Ueki, Masaki Ueno, Kahoru Nishina, Shunichi Shiozawa, and Nobuhiro Maekawa. 2012. “T-5224, a Selective Inhibitor of c-Fos/Activator Protein-1, Attenuates Lipopolysaccharide-Induced Liver Injury in Mice.” Biotechnology Letters 34 (12): 2175–82. doi:10.1007/s10529-012-1022-4.